Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 1042-1047

  Taleb, Soraya ^a,b,c   Cancello, Raffaella ^a,b,c   Poitou, Christine ^a,b,c   Rouault, Christine ^a,b,c   Sellam, Philippe ^d   Levy, Patrick ^d   Bouillot, Jean Luc ^d   Coussieu, Christiane ^d   Basdevant, Arnaud ^a,b,c   Guerre Millo, Michèle ^a,b,c   Lacasa, Danièle ^a,b,c   Clement, Karine ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CATHEPSIN S; CYSTEINE PROTEINASE;

ADIPOSE TISSUE; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORBID OBESITY; PRIORITY JOURNAL; STOMACH SURGERY; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADULT; BLOOD VESSELS; BODY MASS INDEX; BODY WEIGHT; CATHEPSINS; CELL CULTURE TECHNIQUES; FEMALE; HUMANS; OBESITY, MORBID; REFERENCE VALUES; THINNESS; WEIGHT LOSS;

EID: 33644817971     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1601     Document Type: Article

References (33)

1. Abate N 2000 Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14:154-174
2. Grundy SM 2004 Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595-2600
3. Trayhurn P, Wood IS 2004 Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355
4. Lyon CJ, Law RE, Hsueh WA 2003 Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200
5. Ferroni P, Basili S, Falco A, Davi G 2004 Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep 6:424-431
6. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R 2005 Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448-1454
7. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, Nelson KW, Ballantyne CM 2004 Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89:2697-2703
8. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D 2004 Weight loss regulates inflammationrelated genes in white adipose tissue of obese subjects. FASEB J 18:1657-1669
9. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR 2004 The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14:589-600
10. Taleb S, Lacasa D, Bastard JP, Poitou C, Cancello R, Pelloux V, Viguerie N, Benis A, Zucker JD, Bouillot JL, Coussieu C, Basdevant A, Langin D, Clement K 2005 Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 19:1540-1542
11. Chapman HA, Riese RJ, Shi GP 1997 Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88
12. Burns-Kurtis CL, Olzinski AR, Needle S, Fox JH, Capper EA, Kelly FM, McQueney MS, Romanic AM 2004 Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit. Cardiovasc Res 62:610-620
13. Petanceska S, Canoll P, Devi LA 1996 Expression of rat cathepsin S in phagocytic cells. J Biol Chem 271:4403-4409
14. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P 1998 Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102:576-583
15. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP 2003 Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 111:897-906
16. Kos J, Sekirnik A, Kopitar G, Cimerman N, Kayser K, Stremmer A, Fiehn W, Werle B 2001 Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br J Cancer 85:1193-1200
17. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
18. Avogaro A, de Kreutzenberg SV 2005 Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 360:9-26
19. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C 2005 Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 126:121-129
20. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP 2004 Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24:1359-1366
21. Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A, Perrey S, Lee AM, Chapman HA, Libby P 2003 Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 92:493-500
22. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA 1998 Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 101:2351-2363
23. Liu J, Ma L, Yang J, Ren A, Sun Z, Yan G, Sun J, Fu H, Xu W, Hu C, Shi GP, Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis, in press
24. Vazquez LA, Pazos F, Berrazueta JR, Fernandez-Escalante C, Garcia-Unzueta MT, Freijanes J, Amado JA 2005 Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90:316-322
25. Caballero AE 2003 Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11:1278-1289
26. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D 2002 Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809
27. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW 2004 Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 89:4062-4068
28. Kopp HP, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer AF, Schernthaner G 2005 Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes Relat Metab Disord 29:766-771
29. Lindstedt L, Lee M, Oorni K, Bromme D, Kovanen PT 2003 Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem Biophys Res Commun 312:1019-1024
30. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA 1999 Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104:1191-1197
31. Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P, Plasma cystatin-C and development of coronary heart disease: the PRIME Study. Atherosclerosis, in press
32. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P 1998 Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47:913-917
33. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ 2002 Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87:5662-5667